Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Active, not recruiting · NCT05415358 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-04-22 | NCT05415358 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atrium Health Levine Cancer Institute | 27 |
| Atrium Health Wake Forest Baptist | 13 |
| Wake Forest University Health Sciences | 284 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Levine Cancer | Charlotte | United States | 13 |
| Atrium Health Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | United States | 17 |